Get the content you want anytime you want.
REGISTER NOW | SIGN IN

Select coverage from Infectious Disease Week is included below:

Antibiotic Therapy for Staphylococcal Bloodstream Infections: Doing the Same with Less
Researchers found that the use of the treatment algorithm for staphylococcal bacteremia shortens therapy without compromising outcomes.

 
All Antibiotic Orders Should Include Indication for Use
Emily Heil, PharmD, BCPS-AQ ID, sheds light on one of the standards of new antibiotic stewardship regulations: all antibiotic orders should include indication for use.
The Promise and Peril of Second-Generation Beta-Lactam Inhibitor Combinations
Whether the oft-repeated pattern of initial drug success followed by increasing resistance plays out in the future for many drugs remains to be seen.
CD101: A New Long-Acting Echinocandin
David Andes, MD, shares the half-life and dosing intervals for a new long-acting echinocandin.
Ribaxamase Found to Prevent New Onset <em>Clostridium difficile</em> Infections
About 500,000 Americans fall ill from Clostridium difficile infections every year.
Antibiotics Prescribed by Dentists May Be Contributing to CDI Incidence
Dr. Maria Bye, an epidemiologist at the Minnesota Department of Health shares some unsettling news when it comes to C. difficile: dentists’ prescribing habits may be contributing to CDI incidence.
What Are the Results of the REVIVE-2 Trial?
David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.
Addressing the Growing Problem of Resistant Fungi
Candidemia is the most common healthcare-associated bloodstream infection in the United States, with an incidence of 5-15 per 100,000 persons.
FEATURED
We break down our top HIV news stories of 2017. Did you read them all?
x